NDSIB
REGN icon

North Dakota State Investment Board’s Regeneron Pharmaceuticals REGN Stock Holding History

North Dakota State Investment Board’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.88M Buy
3,017
+77
+3% +$52.4K 0.08% 214
2026
Q1 		$2.27M Sell
2,940
-639
-18% -$489K 0.1% 153
2025
Q4 		$2.76M Buy
+3,579
New +$2.43M 0.1% 146

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

North Dakota State Investment Board's REGN Position: Q2 2026 in Review

North Dakota State Investment Board increased its Regeneron Pharmaceuticals (REGN) stake by 2.6% in Q2 2026, buying an estimated $52.4K and bringing the position to 3,017 shares worth $1.88M. The position accounts for 0.08% of the portfolio, ranked #214.

North Dakota State Investment Board first reported a position in REGN in Q4 2025 and has held it in 3 quarters since. The position peaked at $2.76M in Q4 2025. 1,332 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • North Dakota State Investment Board held 3,017 shares of Regeneron Pharmaceuticals worth $1.88M as of Q2 2026.
  • North Dakota State Investment Board bought 77 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $52.4K.
  • Regeneron Pharmaceuticals made up 0.08% of North Dakota State Investment Board's portfolio in Q2 2026, its #214 holding.
  • North Dakota State Investment Board first reported a position in Regeneron Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • North Dakota State Investment Board's Regeneron Pharmaceuticals position peaked at $2.76M in Q4 2025.
  • 1,332 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on North Dakota State Investment Board's 13F filing for Q2 2026, filed 4 Aug 2026.